News ArticleAdani Green Energy Schedules Investor and Analyst Engagement at JM Financial India Xchange Conference 2026
Company to hold physical one-on-one and group meetings in Mumbai on November 16, 2026, subject to change
Adani Green Energy Limited will engage in one-on-one and group meetings with investors and analysts at the JM Financial India Xchange Conference 2026 on November 16, 2026, in Mumbai to discuss company outlook and performance.
Adani Green Energy Limited
General / Other
Adani Green Energy Limited will participate in the JM Financial India Xchange Conference 2026, conducting one-on-one and group meetings with investors and analysts on November 16, 2026, in Mumbai.
The company announced the schedule for its investor and analyst interaction, which will take place physically in Mumbai.
These meetings aim to provide stakeholders with insights about the company’s current operations and strategic direction.
The date of the meeting may be subject to adjustments depending on circumstances affecting the company or the investors.
This interaction is part of the company's commitment to maintaining transparency and engagement with the financial community.
Highlights
- Meetings scheduled for November 16, 2026, in Mumbai at the JM Financial India Xchange Conference.
- Format includes both one-on-one and group discussions.
- Physical attendance is planned for the meetings.
- Date subject to change based on exigencies of investors or the company.
Key Data Snapshot
What happened
- Adani Green Energy notified stock exchanges about upcoming investor and analyst meetings.
- The company will engage stakeholders at the JM Financial India Xchange Conference 2026.
Key details
- Meetings scheduled for November 16, 2026, in Mumbai.
- Interaction formats include one-on-one and group meetings.
- Meetings will be conducted physically.
- Date may change based on investor or company needs.
Regulatory and governance context
- Disclosure made pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Company Secretary Pragnesh Darji signed the communication.
Highlights
- Meetings scheduled for November 16, 2026, in Mumbai at the JM Financial India Xchange Conference.
- Format includes both one-on-one and group discussions.
- Physical attendance is planned for the meetings.
- Date subject to change based on exigencies of investors or the company.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
